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 Abstract
Objective: To determine clinical and histopathological factors in patients with cervical cancer tumors smaller than 
2cm in order to identify those who could be operated less extensively with preservation of reproductive organs and 
lower morbidity.
Material and methods: We retrospectively reviewed the records of patients with cervical cancer and a maximum 
tumor of 2cm in diameter who were qualified for primary surgery in the years 2001-2007 at the Department of 
Gynecologic Oncology, Cancer Center in Warsaw.
Results: From the group of 110 operated patients, 96 were included into the study. Within the analyzed group the 
infiltration of the parametrium was found in 4 women (4.2%). All of them had squamous cell cancer; stage IB, grade 
G3. One patient had a tumor 1.5cm in diameter and 3 patients had tumors up to 2cm in diameter. The involvement 
of lymph nodes was observed in 3 patients with squamous cell carcinoma: in one case the tumor was intermediate 
grade (G2) and in two cases low grade (G3). The lymph nodes were involved only in patients with tumors greater 
than 0.5cm. The lymph vascular space invasion was found in 14 patients (14.7%): in 12 with squamous cell cancer 
and in 2 with adenocarcinoma. The diameter of the tumor was 0.5-1cm in 4 women, 1-1.4cm in 3 women and 1.5-
2cm in the majority (7 women accounted for 29% of all patients in that group). No infiltration of the blood vessels 
could be seen in all 30 women with tumors smaller than 0.5cm. We found a statistically significant relationship 
between the size of the tumor and the incidence of lymph vascular space invasion (p=0.024).
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Introduction
Cervical	cancer	is	the	second	most	common	cancer	among	
women.	The	incidence	in	Poland	in	2008	was	11,2	while	mortality	
reached	5.3	 in	100000	women	 [1].	Surgery	 is	 the	 treatment	of	
choice	in	the	early	stages	of	the	disease	[2].	Commonly	accepted	
risk	 factors	 of	 disease	 recurrence	 include:	 clinical	 stage,	
histological	type,	pathological	grade,	size	of	the	tumor,	depth	of	
infiltration,	 involvement	of	regional	 lymph	nodes,	 involvement	
of	 the	 adnexa,	 vascular	 space	 invasion	 and	 radicality	 of	 the	
primary	 surgery	 [3].	Extensive	 radical	hysterectomy	according	
to	Wertheim	 method	 is	 associated	 with	 significant	 morbidity:	
urinary	bladder	and	bowel	dysfunction,	fistulas,	hematomas	and	
abscesses	 [4,	 5].	 Risk	 of	 complications	 can	 be	 minimized	 by	
limiting	the	extent	of	the	operation.	Due	to	the	effective	use	of	
screening,	an	increasing	number	of	women	are	being	diagnosed	
with	cervical	cancer	at	a	younger	age.	
Many	 of	 these	 women	 are	 of	 childbearing	 age	 and	 wish	
to	preserve	 their	 fertility.	Concurrently,	women	decide	 to	have	
their	first	and	second	child	significantly	later	in	life.	Both,	young	
age	of	cervical	cancer	patients	and	delayed	motherhood	justify	
the	 search	 for	 less	 invasive	 treatment	methods	of	 that	 disease.	
Over	the	past	years	the	extent	of	the	operations	has	been	greatly	
reduced,	 resulting	 in	 smaller	 number	 of	 complications	 and	
preserved	fertility,	but	not	affecting	 treatment	effectiveness	 [6-
9].	The	present	research	identifies		a	group	of	‘low	risk’	patients	
who	could	be	operated	using	less	extensive	techniques.
Aim
We	analyzed	selected	clinical	and	histopathological	factors	
in	patients	with	cervical	cancer	tumors	smaller	than	2cm	in	order	
to	identify	those	who	could	be	operated	less	extensively.
Materials and methods
A	 retrospective	 study	 was	 performed	 using	 the	 database	
of	 patients	 with	 diagnosed	 cervical	 carcinoma	 and	 tumor	 not	
exceeding	 2	 cm	 in	 diameter,	 who	 were	 qualified	 for	 primary	
surgery	 in	 the	 years	 2001-2007	 at	 the	 Gynecologic	 Oncology	
Department,	Maria	Sklodowska-Curie	Memorial	Cancer	Center,	
Warsaw,	 Poland.	 Tumor	 diameter	was	 defined	 on	 the	 basis	 of	
histopathological	examination.	From	the	group	of	110	operated	
patients,	 96	 were	 included	 into	 the	 study.	 These	 patients	 had	
a	post-treatment	follow-up	period	of	no	less	than	12	months.	
Conclusion: In selective cases fertility organ preserving surgery is possible and safe. In the group of patients 
with tumor less than 5 mm in diameter no parametrium involvement or lymph metastases were observed. In such 
situation cervical conisation can be justified. In well-differentiated (G1) tumors less than 2 cm in diameter, less 
radical surgical procedures can also be performed because no treatment failure has been observed .
 Key words: cervical cancer / fertility preservation / treatment
 Streszczenie
Cel pracy: Celem pracy była analiza wybranych czynników klinicznych i histopatologicznych umożliwiajacych 
mniej radykalne leczenie chorych na raka szyjki macicy z guzami do 2cm średnicy. 
Materiał i metody: Grupę badaną stanowiły pacjentki ze zdiagnozowanym rakiem szyjki macicy i guzem wielkości 
do 2cm zakwalifikowane do pierwotnego leczenia operacyjnego w latach 2001-2007 w Klinice Nowotworów 
Narządów Płciowych Kobiecych Instytutu Centrum Onkologii w Warszawie.
Wyniki: Z grupy 110 operowanych chorych do retrospektywnej analizy włączono 96 osób. W analizowanej grupie 
pacjentek naciekanie przymacicz odnotowano u 4 pacjentek (4,2%). We wszystkich tych przypadkach były to raki 
płaskonabłonkowe, w stopniu zaawansowania IB i zróżnicowania G3. Naciek  przymacicz zdiagnozowano u jednej 
chorej z guzem o średnicy 1,5cm, a u 3 kobiet guz miał średnicę 2 cm. Zajęcie węzłów chłonnych odnotowano 
u 3 pacjentek z rakiem płaskonabłonkowym przy czym w jednym przypadku był to rak średniozróżnicowany (G2), 
a w dwóch przypadkach niskozróżnicowany (G3). Zajęcie węzłów chłonnych zaobserwowano jedynie u pacjentek 
z guzami o średnicy większej niż 0,5cm. Zajęcie naczyń chłonnych zaobserwowano u 14 pacjentek (14,7%), u 12 
z rakiem płaskonabłonkowym i 2 z rakiem gruczołowym. U 4 pacjentek rozmiar guza mieścił się w przedziale 
0,5-1cm, u 3 1-1,5cm a  u zdecydowanej większości (7 chorych co stanowiło 29% wszystkich pacjentek w tej 
grupie) 1,5-2cm. Zaobserwowano statystycznie znamienną zależność między rozmiarem guza a zajęciem naczyń 
chłonnych (p=0,024).
Wnioski: W wybranej grupie pacjentek z rakiem szyjki macicy leczenie chirurgiczne pozwalające na zachowanie 
płodności jest bezpieczne i możliwe do wykonania. W grupie chorych z guzem nieprzekraczającym średnicy 5mm 
nie obserwowano naciekania przymacicz ani zajęcia węzłów chłonnych. W tych sytuacjach leczeniem z wyboru 
może być konizacja szyjki macicy. Ze względu na brak niepowodzeń w badanym materiale, mniej radykalne leczenie 
może być również rozważone w grupie pacjetek z dobrze zróżnicowanym guzem(G1) o średnicy nieprzekraczającej 
2cm.
 Słowa kluczowe: nowotwory szyjki macicy / zachowanie płodności / leczenie /   
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The	mean	follow-up	was	5	years	long	(12-105	months).	The	
mean	patient	 age	was	 51.3	 years	 (25-78	 years).	The	 statistical	
analysis	was	performed	using	the	Statistical	Package	for	Social	
Science	software,	version	17.0	(SPSS	Inc.,	IL,	USA).	Descriptive	
statistical	 methods,	 univariate	ANOVA	 test,	 U	Mann-Whitney	
test	and	Spearman	correlation	test	were	applied,	if	appropriate.	
The	 level	 of	 statistical	 significance	 was	 defined	 as	 p<0.05.	
Clinicohistopathological	data	are	presented	in	table	1.
Results
Within	the	analyzed	group	the	infiltration	of	the	parametrium	
was	found	in	4	women	(4.2%).	All	of	 them	had	squamous	cell	
cancer;	stage	IB,	grade	G3.	One	patient	(1.5%)	had	a	tumor	of	
1.5cm	and	3	(3.15%)	patients	had	tumors	of	2cm.	
The	 involvement	 of	 lymph	 nodes	was	 observed	 in	 3.15%	
patients	with	 squamous	 cell	 carcinoma:	 in	 one	 case	 the	 tumor	
was	intermediate	grade	(G2)	and	in	 two	cases	 low	grade	(G3).	
The	 lymph	 nodes	were	 involved	 only	 in	 patients	 with	 tumors	
greater	than	0.5cm.	
The	lymphatic	space	 invasion	was	observed	in	14	patients	
(14.7%):	 in	 12	 (12.6%)	 with	 squamous	 cell	 cancer	 and	 in	 2	
(2.1%)	with	adenocarcinoma.	The	diameter	of	the	tumor	was	0.5-
1cm	in	4	women,	1-1.4cm	in	3	women	and	1.5-2cm	in	7	women,	
what	accounted	for	29%	of	all	patients	in	that	group.	We	found	
a	 statistically	 significant	 relationship	 between	 the	 size	 of	 the	
tumor	and	the	incidence	of	lymphatic	space	invasion	(p=0.024).
Vascular	space	invasion	was	found	in	8	patients.	Although	in	
30	women	with	tumors	smaller	than	0.5cm	there	was	no	vascular	
space	invasion,	invasion	was	confirmed	in	single	cases	from	20	
patients	with	tumors	0.5-1cm	in	diameter	and	from	20	patients	
with	 tumors	 1-1.5cm	 in	 diameter.	 In	 the	 group	 of	 24	 women	
with	tumor	of	1.5-2cm,	the	final		histopathological	examination	
revealed	vascular	space	invasion	in	25%	of	the	cases	(6	patients).	
A	 trend	 towards	statistical	significance	was	observed	(p=0.09).	
The	 authors	 found	 the	 body	 of	 the	 uterus	 to	 be	 involved	 in	 3	
patients	with	various	tumor	diameters:	0.5-1cm,	1-1.5cm	and	1.5-
2cm.	These	cases	included	2	low	grade	(G3)	and	one	intermediate	
grade	(G2)	carcinoma.	Histology	included	two	cases	of	squamous	
cell	carcinomas	and	one	of	adenocarcinoma.	
The	table	II	shows	the	relation	between	tumor	diameter	and	
selected	prognostic	factors.
In	9	patients	(9.3%)	in	the	age	group	of	38	to	69	years	(mean	
52	years)	recurrence	was	noted.	3	patients	had	local	recurrence	
and	6	were	diagnosed	with	distant	metastases.	Out	of	the	latter,	
one	 had	 a	 single	 focus	 in	 the	 liver,	 one	 in	 the	 lungs	 and	 the	
remainder	had	multiple	metastases	in	the	liver,	lungs,	intestines,	
retroperitoneal	 lymph	 nodes,	 spine	 and	 the	 peritoneum.	 The	
mean	time	to	recurrence	was	25	months	(9	to	73	months).	Tumor	
size	in	this	group	was	0.5-1cm	in	3,	1-1.5cm	in	2	and		1.5-2cm	in	
4	patients.	Seven	women	had	a	G3	and	2	had	a	G2	tumor.	Among	
the	patients	diagnosed	with	 recurrence	8	patients	had	 stage	 IB	
disease	and	1	patient	stage	IIA	disease.	
None	of	the	patients	with	recurrence	had	infiltration	of	either	
the	 adnexa	 or	 the	 body	 of	 the	 uterus.	 8	 out	 of	 9	women	with	
recurrence	underwent	total	Wertheim-Meigs	hysterectomy	and	1	
had	a	total	laparoscopic	radical	hysterectomy.	In	our	observation	
the	time	to	recurrence	significantly	depended	on	the	fact	whether	
vascular	space	was	invaded	(p=0.016).	
In	 the	 case	 of	 low	 grade	 cancers	 (G3)	 (p=0.071)	 and	 in	
the	case	of	infiltrated	lymph	nodes	(p=0.079)	the	authors	noted	
a	trend	towards	statistical	significance.
In	 the	analyzed	group	of	96	patients	7	died	(7.3%).	 In	 the	
group	of	66	women	with	confirmed	invasive	carcinoma	3	died	
due	to	disease	progression.	
Disease stage Number of patients
IA 8 8,3%
IB 82 85,4%
IIA 6 6,2%
 96  
Histopathological diagnosis Number of patients
Squamous cell carcinoma 83 86,5%
Adenocarcinoma 11 11,5%
Clear-cell carcinoma 2 2,1%
 96  
Grade Number of patients
High grade (G1) 8 12,1%
Intermediate  grade (G2) 27 40,9%
Low grade (G3) 31 47,0%
 66  
Final histopathological diagnosis Number of patients
Invasive cancer 66 68,8%
Pre-invasive cancer 22 22,9%
Micro-invasive cancer 6 6,3%
Cervix inflammation 2 2,1%
 96  
Accomplished procedures Number of patients
Conization 1 1,0%
Wertheim-Meigs hysterectomy 78 81,30%
Laparoscopically assisted vaginal 
hysterectomy (LAVH) 2 2,1%
Total abdominal hysterectomy (TAH/
BSO) 4 4,2%
Total laparoscopic hysterectomy 
(TLRH) 11 11,5%
96
Adjunctive treatment Number of patients
Brachytherapy 34 73,9%
Radiotherapy 2 4,3%
Radiotherapy and brachytherapy 2 4,3%
Radiochemotherapy and brachytherapy 7 15,2%
Chemotherapy 1 2,2%
 46  
Table I. Clinicohistopathological characteristics of patients.  
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The	mean	time	to	death	was	24.3	months	(12-42	months).	
Two	 patients	 died	 due	 to	 other	 reasons	 (leukemia	 –	 after	 41	
months	and	lung	cancer	–	after	97	months).	In	the	group	of	30	
patients	with	pre-invasive	or	minimally	invasive	cancer	2	died	–	1	
due	to	kidney	cancer	and	1	due	to	massive	pulmonary	embolism	
following	 cholecystectomy.	 In	 that	 group	 the	 authors	 did	 not	
observed	deaths	secondary	to	cervical	cancer	progression.
Discussion
Despite	advances	in	diagnosis	and	management	of	cervical	
cancer,	 as	 well	 as	 the	 introduction	 of	 prophylactic	 human	
papillomavirus	 vaccines,	 the	 disease	 remains	 a	 major	 cause	
of	 cancer	 related	 mortality.	 The	 number	 of	 deaths	 caused	 by	
cervical	 cancer	 in	2008	 reached	1745,	which	 constituted	4.3%	
of	all	cancer-related	deaths	(seventh	position	among	deaths)	[1].	
Most	 incidence	 and	 death	 cases	 concern	 middle	 aged	 woman	
(45-65	years).	However,	young	women	(18-44	years)	account	for	
18%	of	all	cases.	In	2007	over	340	new	cases	were	diagnosed	in	
women	under	40	years	of	age	[10].
Treatment	options	for	women	with	disease	confined	to	 the	
cervix	 and	 upper	 vagina	 (stages	 IA-IIA)	 include	 either	 radical	
surgery	or	radiotherapy.	A	prospective	study	conducted	on	343	
women	 randomized	 to	 either	 radical	 hysterectomy	 or	 pelvis	
irradiation	 revealed	 that	 survival	 rates	were	similar.	Neither	of	
the	two	treatment	strategies	proved	to	be	superior	[11].	Choice	
of	 a	 particular	 treatment	 method	 is	 often	 dictated	 by	 patient	
related	factors,	side	effect	profiles,	and	physician	preference.	The	
traditional	Wertheim	hysterectomy	(type	III)	includes	removal	of	
the	uterus,	upper	vagina,	uterosacral	 ligaments	with	 ligation	of	
the	uterine	artery	at	its	origin	and	resection	of	the	parametrium.	
Although	 such	operation	often	 results	 in	 excellent	 local	 tumor	
control,	 it	 is	 associated	 with	 significant	 	 morbidity	 [4,	 5,	 12,	
13,	14].	Late	complications	occur	 in	40%	of	operated	patients.	
One	of	 the	most	frequent,	seen	in	almost	one	third	of	cases,	 is	
urinary	bladder	dysfunction	[12,	15].	Most	of	the	complications	
may	 be	 due	 to	 the	 resection	 of	 the	 parametrium	 because	 that	
tissue	contains	autonomic	fibres	which	play	a	significant	role	in	
bladder	and	bowel	 innervation,	as	well	as	 sexual	performance.	
The	rationale	for	the	resection	of	the		parametrium	is	to	remove	
potential	neoplastic	foci.	This	benefit,	however,	 is	debatable	 in	
cases	of	early	stage	of	the	disease	[16,	17].
Within	the	analyzed	group,	only	3	out	of	73	patients	(4.1%)	
who	underwent	radical	Wertheim-Meigs	hysterectomy	and	4	in	
the	whole	study	group	had	infiltrated	parametrium.	
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0-0,5
P
30 0 0 0 0 0 0
31,3%       
G
1 0 0 0 0 0 0
1,0%  
J
0 0 0 0 0 0 0
 
0,6-1,0
P
17 1 1 4 0 0 0
17,7% 1,0% 1,0% 4,2%    
G
2 0 0 0 1 0 0
2,1% 1,0%
J
1 0 0 0 0 0 0
1,0%
1,1-1,5
P
17 1 1 3 1 0 1
17,7% 1,0% 1,0% 3,1% 1,0%  1,0%
G
4 0 0 0 0 0 0
4,2%  
J
0 0 0 0 0 0 0
 
1,6-2,0
P
19 1 4 5 1 0 3
19,8% 1,0% 4,2% 5,2% 1,0%  3,1%
G
4 0 2 2 0 0 4
4,2%  
J
1 0 0 0 0 0 0
1,0%
                 
                   abbreviations: P-squamous cell carcinoma, G-adenocarcinoma, J-clear-cell carcinoma
Table II. Relation between tumor diameter and selected prognostic factors.  
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All	patients	were	in	stage	1B	disease	and	in	75%	cases	(3	
patients)	 the	 tumor	 diameter	 was	 2cm	 (1.5-2cm).	 The	 authors	
found	no	evidence	of	parametrium	infiltration,	either	in	case	of	
G1	and	G2	neoplasms	or	in	patients	with	no	lymphatic	vascular	
space	 invasion	 (LVSI).	 Our	 data	 support	 already	 published	
findings	where	parametrium	is	reported	to	be	infiltrated	in	4%	to	
39%	of	cases	with	disease	stage	IA-IIA	[18-24].
Many	 investigators	 studied	 the	 possibility	 of	 preserving	
fertility	through	less	radical	surgery	in	selected	low-risk	patients.	
Kinney	 et	 al.,	 evaluated	 83	 patients	with	 stage	 IB1	 squamous	
cell	 cervical	 cancer,	 tumor	 size	 not	 greater	 than	 2cm	 and	 no	
involvement	 lymphatic	vascular	 space	 invasion.	None	of	 these	
patients	had	evidence	of	parametrium	infiltration	[25].	Another	
group	of	842	women	with	stage	IA1	to	IB1	cancer,	treated	with	
hysterectomy,	 was	 studied	 by	 Covens	 et	 al.	 The	 parametrium	
was	 infiltrated	 in	 33	 patients	 (4%),	 and	 the	 risk	 of	 infiltration	
was	related	to	the	large	tumor	size,	LVSI,	deep	infiltration	and	
invaded	pelvic	lymph	nodes.	Additional	analyses	of	536	patients	
with	 tumor	 diameter	 not	 exceeding	 2cm,	 negative	 histological	
examination	 of	 pelvic	 lymph	 nodes	 	 revealed	 parametrium	
involvement	only	in	0.6%	of	cases	[18].	
Wright	et	al.,	studied	risk	factors	of	parametrium	infiltration	
in	 498	 patients.	 The	 parametrium	 involvement	 was	 observed	
only	 in	 6%	 of	women	with	 negative	 pelvic	 lymph	 nodes,	 and	
in	47,9%	of	patients	with	infiltrated	lymph	nodes.	Moreover,	in	
the	first	group	the	risk	was	only	0.4%	if	the	tumor	was	smaller	
than	2cm	and	no	LVSI	could	be	observed.	The	risk	factors	for	
parametrium	 involvement	 were:	 LVSI,	 tumor	 size	 >2cm,	 and	
infiltration	of	pelvic	and		paraaortic	lymph	nodes	(p<0.001)	[26].	
These	data	are	similar	to	ours.	However,	we	observed	infiltrated	
parametrium	 also	 in	 one	 case	 where	 the	 tumor	 diameter	 was	
1.5cm.	No	infiltration	was	found	in	patients	with	no	LVSI.	No	
vascular	 space	 invasion	 was	 found	 in	 any	 patient	 with	 tumor	
diameter	smaller	than	0.5cm.	The	risk	of	vascular	ad	lymphatic	
vascular	space	invasion	was	statistically	related	to	the	tumor	size	
(p=0.024	and	p=0.09).
The	size	of	 the	 tumor	 is	an	 independent	prognostic	 factor.	
Women	with	tumors	not	exceeding	2cm	survive	in	about	90%,	
while	those	with	larger	lesions	–	in	60%	[27].	In	our	group	we	
have	 noted	 recurrence	 in	 9	 cases.	All	 of	 them	 had	 low	 grade	
(G3)	neoplasm	and	 tumor	 larger	 than	0.5cm.	Deaths	 related	 to	
progression	occurred	in	3	cases.	In	all	patients	the	tumor	diameter	
was	at	least	1.5cm,	and	none	of	them	had	a	high	grade	disease	
(G1).We	 observed	 no	 disease	 related	 deaths	 in	 patients	 with	
high	grade	 (G1)	 neoplasms	 and	 tumor	diameter	 not	 exceeding	
1cm.	It	seems	therefore	that	this	group	of	patients	might	include	
candidates	for	less	extensive	treatment.	
The	tumor	size	is	an	important	risk	factor	in	patients	planned	
for	 less	 extensive	 surgery	 [8,	 28,	 29].	 In	 our	 study	 the	 tumor	
size	 was	 determined	 during	 histopathological	 examination.	
Nevertheless,	 it	 	 seems	 possible	 that	 colposcopy	 along	 with	
magnetic	resonance	imaging	(MRI)	and	ultrasonography		could	
accurately	determine	the	tumor	size.	The	results	of	treatment	in	
such	patients	are	very	good.	In	cases	where	tumors	smaller	than	
2cm	do	not	infiltrate	beyond	one	half	of	the	wall	thickness	of	the	
cervix,	5-year	survival	reaches	95%	[8,	29-31].	
The	involvement	of	the	lymph	nodes	was	seen	only	in	cases	
of	 	 intermediate	 and	 low	 grade	 cancers	 (G2	 and	G3).	 One	 of	
these	cases	presented	with	a	tumor	of	only	0.9cm.	It	seems	that	
in	 the	 group	of	 patients	with	 tumors	 no	greater	 than	1cm	 it	 is	
not	necessary	to	perform	radical	hysterectomy	with	parametrium	
excision.	 Cervical	 conisation	 or	 simple	 hysterectomy	 may	 be	
just	as	sufficient.	Nevertheless,	the	examination	of	lymph	nodes	
remains	 necessary	 as	 also	 in	 such	 pre-selected	 groups	 node	
infiltration	was	documented.
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8 IB G3 1.5-2 n n n n n rthchth n
9 IB G2 1-1.5 n T n n n brth n
abbreviations: n – no,  y – yes
Table III. Data on patients with recurrence 
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Conclusions
In	selective	cases	fertility	organ	preserving	surgery	is	possible	
and	safe.	In	the	group	of	patients	with	tumor	less	than	5	mm	in	
diameter	no	parametrium	involvement	or	lymph	metastases	were	
observed.	In	such	situations	cervical	conisation	can	be	justified.	
In	well-differentiated	 (G1)	 tumors,	 less	 than	2	cm	in	diameter,	
less	radical	surgical	procedures	can	also	be	performed	because	
no	treatment	failure	has	been	observed.
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